FINACEA FOAM
NDC 50222-303, azelaic acid, aerosol, foam, from LEO Pharma Inc..
- Product NDC
- 50222-303
- Status
- Listed
- Labeler
- LEO Pharma Inc.
- Dosage form
- AEROSOL, FOAM
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA207071
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50222-303 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZELAIC ACID.15 g/g
Pharmacologic classes
Decreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50222-303-50 | 50222030350 | 1 CAN in 1 CARTON (50222-303-50) / 50 g in 1 CAN |
| 50222-303-91 | 50222030391 | 1 CAN in 1 CARTON (50222-303-91) / 15 g in 1 CAN |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9fabd24e-4c3b-49a0-aa5f-c8d75ae67572NADAC price for package 50222030350
GET /v1/drugs/nadac/50222030350
Use it
Look up 50222-303 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50222-303 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50222-303. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.